Federal Momentum for Psychedelic and Emerging Behavioral Health Treatments: Key Legal Considerations
This Bulletin is brought to you by AHLA’s Behavioral Health Practice Group.
- May 11, 2026
- Alicia Macklin , Hooper Lundy & Bookman PC
- Caitlin Callahan , Hooper Lundy & Bookman PC
On April 18, 2026, the Trump administration issued an Executive Order, entitled Accelerating Medical Treatments for Serious Mental Illness, and launched a $139 million Advanced Research Projects Agency for Health (ARPA-H) initiative—both actions aimed at facilitating research on psychedelic drugs for mental health treatment.
ARTICLE TAGS
You must be logged in to access this content.